[An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease].
Jiménez Jiménez
F J
FJ
Hospital del INSALUD Nuestra Señora Virgen del Puerto, Plasencia, Cáceres.
Ladero Quesada
J M
JM
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002415:Cats; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D008954:Models, Biological; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D051381:Rats; D013329:Structure-Activity Relationship
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Modelo experimental de parkinsonismo por una neurotoxina: implicaciones en la clínica y en la etiología de la enfermedad de Parkinson.